News for companies (in Biotechnology only).

News for companies (in Biotechnology only). http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Wed, 08 Feb 2012 04:02:05 +0100 Wed, 08 Feb 2012 04:02:05 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184 http://www.lifescience-online.com/Idenix_Announces_Removal_of_the_Partial_Clinical_H,30795.html?portalPage=Lifescience+Today.News

Area :: Anti-Infective
Category :: Scientific - Pipeline - Regulatory
Related companies :: IDENIX PHARMACEUTICALS INC
Related drugs :: IDX-184

]]> Thu, 02 Feb 2012 23:00:00 GMT News Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results http://www.lifescience-online.com/Gilead_Sciences_Announces_Fourth_Quarter_and_Full_,30790.html?portalPage=Lifescience+Today.News

Category :: Finance and Income
Related companies :: GILEAD SCIENCES INC

]]> Wed, 01 Feb 2012 23:00:00 GMT News Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis Print http://www.lifescience-online.com/Agennix_AG_Halts_Phase_II_III_OASIS_Trial_in_Sever,30778.html?portalPage=Lifescience+Today.News

Area :: Immunomodulation
Category :: Scientific - Pipeline - Regulatory
Related companies :: AGENNIX AG
Related drugs :: TALACTOFERRIN

]]> Wed, 01 Feb 2012 23:00:00 GMT News Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma http://www.lifescience-online.com/Curis_Announces_FDA_Approval_of_Erivedge_TM___vism,30771.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: CURIS INC
Related drugs :: VISMODEGIB

]]> Sun, 29 Jan 2012 23:00:00 GMT News FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma http://www.lifescience-online.com/FDA_Approves_Erivedge__Vismodegib__Capsule__the_Fi,30756.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: GENENTECH INC
ROCHE HOLDING LTD
Related drugs :: VISMODEGIB

]]> Sun, 29 Jan 2012 23:00:00 GMT News ZIOPHARM Oncology Announces Recommendation by Independent Data Monitoring Committee to Continue Phase 3 Study of Palifosfamide in Metastatic Soft Tissue Sarcoma http://www.lifescience-online.com/ZIOPHARM_Oncology_Announces_Recommendation_by_Inde,30775.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: ZIOPHARM ONCOLOGY INC
Related drugs :: PALIFOSFAMIDE

]]> Sun, 29 Jan 2012 23:00:00 GMT News ACT Announces Aberdeen Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration http://www.lifescience-online.com/ACT_Announces_Aberdeen_Royal_Infirmary_in_Scotland,30782.html?portalPage=Lifescience+Today.News

Area :: Ophthalmology
Category :: Scientific - Pipeline - Regulatory
Related companies :: Advanced Cell Technology Inc
Related drugs :: RPE CELLS

]]> Sun, 29 Jan 2012 23:00:00 GMT News Seattle Genetics and Millennium Report Data from Phase I Trial of ADCETRIS(TM) in Front-line Mature T-Cell Lymphomas http://www.lifescience-online.com/Seattle_Genetics_and_Millennium_Report_Data_from_P,30731.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: MILLENNIUM PHARMACEUTICALS INC
SEATTLE GENETICS INC
Related drugs :: BRENTUXIMAB VEDOTIN

]]> Thu, 26 Jan 2012 23:00:00 GMT News